<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30306595</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>11</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1096-9896</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>10</Day>                    </PubDate>                </JournalIssue>                <Title>The Journal of pathology</Title>                <ISOAbbreviation>J. Pathol.</ISOAbbreviation>            </Journal>            <ArticleTitle>Keratin 17 in disease pathogenesis: from cancer to dermatoses.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1002/path.5178</ELocationID>            <Abstract>                <AbstractText>Keratin 17 (K17) is a type I intermediate filament mainly expressed in the basal cells of epithelia. As a multifaceted cytoskeletal protein, K17 regulates a myriad of biological processes, including cell proliferation and growth, skin inflammation and hair follicle cycling. Aberrant overexpression of K17 is found in various diseases ranging from psoriasis to malignancies such as breast, cervical, oral squamous and gastric carcinomas. Moreover, genetic mutation in KRT17 is related to tissue-specific diseases, represented by steatocystoma multiplex and pachyonychia congenita. In this review, we summarize our findings concerning the regulatory mechanisms of K17 overexpression in psoriasis and compare them to the literature relating to other diseases. We discuss data that pro-inflammatory cytokines including IL-17, IL-22, IFN-γ, TGF-β and transcription factors Gli1/2, Nrf2 and p53 can regulate K17 by transcriptional and translational control. Moreover, post-translational modification including phosphorylation and ubiquitination are involved in the regulation of K17 stability and biological functions. We therefore review the current understanding of K17 regulatory mechanism and its pathogenic role in diseases from dermatoses to cancer. Prospects for anti-K17 therapy in diagnosis, prognosis and disease treatment are also discussed.</AbstractText>                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Yang</LastName>                    <ForeName>Luting</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Shaolong</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Gang</ForeName>                    <Initials>G</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5842-8080</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>10</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>J Pathol</MedlineTA>            <NlmUniqueID>0204634</NlmUniqueID>            <ISSNLinking>0022-3417</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Keratin 17</Keyword>            <Keyword MajorTopicYN="N">breast</Keyword>            <Keyword MajorTopicYN="N">cervix</Keyword>            <Keyword MajorTopicYN="N">dermatoses</Keyword>            <Keyword MajorTopicYN="N">p27</Keyword>            <Keyword MajorTopicYN="N">pachyonychia congenita</Keyword>            <Keyword MajorTopicYN="N">psoriasis</Keyword>            <Keyword MajorTopicYN="N">squamous cell carcinoma</Keyword>            <Keyword MajorTopicYN="N">steatocystoma multiplex</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>07</Month>                <Day>05</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>09</Month>                <Day>17</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>02</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30306595</ArticleId>            <ArticleId IdType="doi">10.1002/path.5178</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>